Back to Trades
Klein Lawrence Otto
Chief Executive OfficerDirectorCIK 0001762583
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 6
- Buy transactions
- 0
- Sell transactions
- 6
- Companies
- 2
- Active
- 2026
Klein Lawrence Otto, Chief Executive Officer, Director, has filed 6 SEC reports (2026), spread across 2 companies, totaling $19.6M in disclosed volume. Weighing $0 bought versus $7.3M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Sep 15 | ORKA Oruka Therapeutics, Inc. | Klein Lawrence Otto | Chief Executive Officer, Director | Sell | $234.7K |
| Sep 1 | ORKA Oruka Therapeutics, Inc. | Klein Lawrence Otto | Chief Executive Officer, Director | Sell | $6.9M |
| Jun 15 | ORKA Oruka Therapeutics, Inc. | Klein Lawrence Otto | Chief Executive Officer, Director | Sell | $120.5K |
| Jun 11 | JBIO Jade Biosciences, Inc. | Klein Lawrence Otto | Insider | Award | $530.3K |
| Mar 17 | ORKA Oruka Therapeutics, Inc. | Klein Lawrence Otto | Chief Executive Officer, Director | Sell | $71.4K |
| Jan 23 | ORKA Oruka Therapeutics, Inc. | Klein Lawrence Otto | Chief Executive Officer, Director | Grant | $10.5M |
6 filings